Inflammation and mortality in a frail mouse model

Age

Volumn 34, Issue 3, 2012, Pages 705-715

  Ko, Fred ^a   Yu, Qilu ^b   Xue, Qian Li ^b   Yao, Wenliang ^b   Brayton, Cory ^b   Yang, Huanle ^b   Fedarko, Neal ^b   Walston, Jeremy ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

C57BL 6; Frailty; IGF 1; IL 10; IL 6; Inflammation; Mortality

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN A; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; ANIMAL TISSUE; ARTICLE; AUTOPSY; BREAST ADENOCARCINOMA; BRONCHOPNEUMONIA; CAUSE OF DEATH; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOCRINE FUNCTION; FEMALE; FRAIL ELDERLY; GENOTYPE; HISTIOCYTIC OTITIS; HISTIOCYTIC SARCOMA; INFLAMMATION; LONGITUDINAL STUDY; LUNG ADENOMA; LUNG INFILTRATE; LYMPHOMA; MALE; MORTALITY; MOUSE; NEOPLASM; NONHUMAN; OTITIS MEDIA; OVERALL SURVIVAL; RESPIRATORY TRACT DISEASE; SEX RATIO; SKIN SARCOMA; SOLID PHASE SYNTHESIS; SUBCUTANEOUS TISSUE; SURVIVAL; THYROID ADENOMA; THYROID CARCINOMA; URINARY TRACT INFECTION;

AGING; ANIMALS; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; INFLAMMATION; MICE; MICE, INBRED C57BL;

EID: 84863728010     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9269-6     Document Type: Article

References (40)

1. Bartke A (2008) Impact of reduced insulin-like growth factor-1/ insulin signaling on aging in mammals: novel findings. Aging Cell 7(3):285-290 (Pubitemid 351663898)
2. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384(6604):33
3. Bodell PW, Kodesh E, Haddad F, Zaldivar FP, Cooper DM, Adams GR (2009) Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 106(2):443-453
4. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP (2003) Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88 (5):2019-2025 (Pubitemid 36549871)
5. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G et al (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59(3):242-248 (Pubitemid 38375337)
6. Chiba T, Yamaza H, Shimokawa I (2007) Role of insulin and growth hormone/insulin-like growth factor-I signaling in lifespan extension: rodent longevity models for studying aging and calorie restriction. Curr Genomics 8 (7):423-428 (Pubitemid 351486273)
7. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E et al (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292(5514):104-106 (Pubitemid 32289136)
8. Cohen HJ, Harris T, Pieper CF (2003) Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 114(3):180-187 (Pubitemid 36294002)
9. Chomarat P, Rissoan MC, Banchereau J, Miossec P (1993) Interferon gamma inhibits interleukin 10 production by monocytes. P J Exp Med 177(2):523-527 (Pubitemid 23117103)
10. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041
11. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ et al (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47(6):639-646 (Pubitemid 29266628)
12. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815
13. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3): M146-M156 (Pubitemid 32187141)
14. Guarente L, Kenyon C (2000) Genetic pathways that regulate ageing in model organisms. Nature 408(6809):255-262
15. Haddad F, Zaldivar F, Cooper DM, Adams GR (2005) IL-6- induced skeletal muscle atrophy. J Appl Physiol 98 (3):911-917 (Pubitemid 40283672)
16. Hanada T, Yoshimura A (2002) Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 13(4-5):413-421
17. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(5):506-512 (Pubitemid 29231100)
18. Kelley KW (2004) From hormones to immunity: the physiology of immunology. Brain Behav Immun 18(2):95-113 (Pubitemid 38173053)
19. Kelley KW, Weigent DA, Kooijman R (2007) Protein hormones and immunity. Brain Behav Immun 21(4):384-392 (Pubitemid 46553732)
20. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75(2):263-274 (Pubitemid 23320290)
21. Leng S, Chaves P, Koenig K, Walston J (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50(7):1268-1271 (Pubitemid 34774552)
22. Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, BlairMet al (2004) Serumlevels of insulin-like growth factor- I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16(2):153-157 (Pubitemid 38714057)
23. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879-884
24. Leng SX, Xue QL, Tian J, Huang Y, Yeh SH, Fried LP (2009) Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I. Exp Gerontol 44:511-516
25. MasternakMM, Al-Regaiey KA, Del Rosario LimMM, Jimenez- Ortega V, Panici JA, Bonkowski MS et al (2005) Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice. Exp Gerontol 40(8-9):679-684 (Pubitemid 41265818)
26. Miller RA (2009) The aging immune system: primer and prospectus. Science 273:70-74
27. Moore KW, O'Garra A, De Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165
28. Mourkioti F, Rosenthal N (2005) IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol 26(10):535-542 (Pubitemid 41297684)
29. Rennick D, Davidson N, Berg D (1995) Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol 76(3 Pt 2):S174-S178
30. Salminen A, Kaarniranta K (2010) Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell Signal 22(4):573-577
31. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292(5514):107-110 (Pubitemid 32289137)
32. Tatar M (2009) Can we develop genetically tractable models to assess healthspan (rather than life span) in animal models? J Gerontol A Biol Sci Med Sci 64:161-163
33. Tripp CS, Wolf SF, Unanue ER (1993) Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725
34. Varadhan R, Seplaki CL, Xue QL, Bandeen-Roche K, Fried LP (2008) Stimulus-response paradigm for characterizing the loss of resilience in homeostatic regulation associated with frailty. Mech Ageing Dev 129:666-670
35. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333-2341 (Pubitemid 35332516)
36. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA et al (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/ National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54(6):991-1001 (Pubitemid 43847040)
37. Walston J, Fedarko N, Yang H, Leng S, Beamer B, Espinoza S et al (2008) The physical and biological characterization of a frail mouse model. J Gerontol A Biol Sci Med Sci 63 (4):391-398 (Pubitemid 351738421)
38. Wolf E, Kahnt E, Ehrlein J, Hermanns W, Brem G, Wanke R (1993) Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models. Mech Ageing Dev 68 (1-3):71-87
39. Yao X, Li H, Leng SX (2011) Inflammation and immune system alterations in frailty. Clin Geriatr Med 27:79-87
40. Yuan R, Tsaih SW, Petkova SB, de Evsikova CM, Xing S, Marion MA et al (2009) Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8(3):277-287